-- 路透社週四引述一份法案草案報道稱，美國國會已縮減一項旨在限制中國晶片製造設備的法案，以確保其潛在影響範圍更小。 路透社通報稱，根據《多邊技術控制硬體協調法案》（MATCH Act），仍將對總部位於荷蘭的ASML公司生產的深紫外浸沒式光刻機實施全國範圍的限制。 報導稱，這項由兩黨共同提出的《多邊技術控制硬體協調法案》（MATCH Act）將有助於美國保持在人工智慧技術領域的領先地位。 報道稱，先前的草案將強制盟友遵守美國的管制措施，並實施全國範圍和針對特定公司的限制。 路透社稱，國會一直在根據川普總統放寬對先進晶片的限制，起草新的晶片限制立法。 （市場動態新聞來自與全球市場專業人士的對話。這些資訊被認為是來自可靠來源，但可能包含傳聞和猜測。準確性無法保證。）
Related Articles
Asia
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
$ASX:NAB
Asia
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
$ASX:CUV
Asia
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.
$ASX:XRF